6-((3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)amino)-1,3-dimethylpyrimidine-2,4(1H,3H)-dione

Catalog No. :
ACFIVH557
CAS No. :
34661-75-1
Molecular Formula :
C20H29N5O3
Molecular Weight :
387.48

IUPAC Name:6-((3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)amino)-1,3-dimethylpyrimidine-2,4(1H,3H)-dione

6-((3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)amino)-1,3-dimethylpyrimidine-2,4(1H,3H)-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-((3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)amino)-1,3-dimethylpyrimidine-2,4(1H,3H)-dione
IUPAC Name6-((3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)amino)-1,3-dimethylpyrimidine-2,4(1H,3H)-dione
MDL No.MFCD00133908
Molecular FormulaC20H29N5O3
Molecular Weight387.48
SMILESCOC1=CC=CC=C1N1CCN(CCCNC2=CC(=O)N(C)C(=O)N2C)CC1
InChI KeyICMGLRUYEQNHPF-UHFFFAOYSA-N
SynonymEbrantil (TN) | Prestwick2_000905 | SPBio_001183 | B-66256 | ICMGLRUYEQNHPF-UHFFFAOYSA-N | CS-0009600 | DTXCID501425 | 2,4(1H,3H)-Pyrimidinedione, 6-((3-(4-(2-methoxyphenyl)-1-piperazinyl)propyl)amino)-1,3-dimethyl- | NCGC00016066-16 | 5-25-15-00402 (Beil
CAS No.34661-75-1
PubChem CID5639

Synthetic Route by SureRoute

1. ACFIVH557 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACGHZA732 route compound structure diagram
    ACGHZA7326972-27-6 In Stock
  4. Then
  5. ACFIVH557 route product structure diagram
    ACFIVH55734661-75-1
Inquiry

2. ACFIVH557 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRMJD712 route compound structure diagram
    ACRMJD7126642-31-5 In Stock
  4. Then
  5. ACFIVH557 route product structure diagram
    ACFIVH55734661-75-1
Inquiry

Comments (0)